Advertisement

American Society of Hematology Annual Meeting & Exposition

newsroom

Featured

Conference Coverage
Conference Coverage
02/23/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers assessed the efficacy of venetoclax-based treatments for patients with relapsed/refractory chronic lymphocytic leukemia. This study was presented at the 65th ASH Annual Meeting & Exposition...
02/23/2024
Conference Coverage
Conference Coverage
01/09/2024

Nirmish Shah, MD

Nirmish Shah, MD
In this podcast, Nirmish Shah, MD, discusses using machine learning and leveraging data analysis to make patient predictions about pain and readmission, to use interventions to minimize complications. Dr...
01/09/2024
Conference Coverage
Conference Coverage
12/29/2023

Pinkal Desai, MD

Pinkal Desai, MD
In this podcast, Pinkal Desai, MD, discusses the impact of previous chemotherapy and/or radiation exposure in patients who go on to develop acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS),...
12/29/2023
Advertisement

Conference Coverage

Conference Coverage
Conference Coverage
02/23/2024

Anthony Calabro, MA

Anthony Calabro, MA
Researchers assessed the efficacy of venetoclax-based treatments for patients with relapsed/refractory chronic lymphocytic leukemia. This study was presented at the 65th ASH Annual Meeting & Exposition...
02/23/2024
Conference Coverage
Conference Coverage
12/18/2023

Anthony Calabro, MA

Anthony Calabro, MA
In effort to understand the effect of the COVID-19 pandemic among patients with sickle cell disease, researchers compared outcomes and characteristics of hospitalized patients both before and during the...
12/18/2023
Conference Coverage
Conference Coverage
12/12/2023

Anthony Calabro, MA

Anthony Calabro, MA
In their case-controlled study that utilized the National Inpatient Sample 2016-2019 database, researchers set out to examine the relationship between leukemia and sickle cell trait.
12/12/2023
Immunology
virus immune cells
Immunology
12/31/2021
The researchers analyzed 569 patients with multiple myeloma, stratified patients on the basis of their percentage of CD56-expressing clonal MM cells, and then evaluated patient outcomes based on this...
12/31/2021
Tumors
cancer cells
Tumors
12/14/2021
To examine the prognostic value of flow cytometry plus PET/CT scanning for detecting minimal residual disease in patients with multiple myeloma, researchers conducted an observational cohort study of 94...
12/14/2021

Clinical Insights

Conference Coverage
Conference Coverage
01/09/2024

Nirmish Shah, MD

Nirmish Shah, MD
In this podcast, Nirmish Shah, MD, discusses using machine learning and leveraging data analysis to make patient predictions about pain and readmission, to use interventions to minimize complications. Dr...
01/09/2024
Conference Coverage
Conference Coverage
12/29/2023

Pinkal Desai, MD

Pinkal Desai, MD
In this podcast, Pinkal Desai, MD, discusses the impact of previous chemotherapy and/or radiation exposure in patients who go on to develop acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS),...
12/29/2023
Conference Coverage
Conference Coverage
12/22/2023

Nirmish R. Shah, MD

Nirmish R. Shah, MD
In this podcast, Nirmish Shah, MD, discusses an overview, the results, and the preclinical and clinical impact of the study titled Preclinical and Clinical Use of AB1, a DNMT1 Protein Depleter, to...
12/22/2023
Expert Q&A
Expert Q&A
06/16/2023
Lead study author Lana Mucalo, MD, discusses her team’s study examining the prevalence of opioid-related mortality in patients with sickle cell disease from 2013 to 2019. She presented her research at the...
06/16/2023
Podcast
Podcast
02/21/2023
In this podcast, Santosh L Saraf, MD, discusses the decline of estimated glomerular filtration rate in patients with sickle cell disease as an indicator of kidney disease progression. Dr Saraf presented on...
02/21/2023